{"id":"NCT01229371","sponsor":"Crucell Holland BV","briefTitle":"Immunogenicity and Safety Study to Assess Influenza Vaccine Formulated With Haemagglutinin (HA) Antigen From Two Suppliers","officialTitle":"Randomized, Parallel-group, Double-blind Multi-center Phase III Study to Assess the Immunogenicity and Safety of the 2010/2011-season Influenza Vaccine Formulated With Haemagglutinin (HA) Antigen From Two Suppliers, in Elderly and Young Adults","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2010-10","primaryCompletion":"2010-12","completion":"2010-12","firstPosted":"2010-10-27","resultsPosted":"2013-03-22","lastUpdate":"2013-09-09"},"enrollment":440,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"PREVENTION"},"conditions":["Influenza"],"interventions":[{"type":"BIOLOGICAL","name":"Inflexal V influenza vaccine (CSL HA Antigen) 2010","otherNames":[]},{"type":"BIOLOGICAL","name":"Inflexal V influenza vaccine (AdImmune HA antigen) 2010/2011","otherNames":[]}],"arms":[{"label":"Subjects ≥18 to ≤60 Years - CSL HA Antigen","type":"ACTIVE_COMPARATOR"},{"label":"Subjects >60 Years - CSL HA Antigen","type":"ACTIVE_COMPARATOR"},{"label":"Subjects ≥18 to ≤60 Years - AdImmune HA Antigen","type":"EXPERIMENTAL"},{"label":"Subjects >60 Years - AdImmune HA Antigen","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to assess the humoral immune response and safety of the parenteral formulation of the 2010/2011-season virosomal subunit influenza vaccine Inflexal V using two different HA antigen suppliers (AdImmune and CSL), in groups of young and elderly adults, using the EMA (European Medicines Agency) regulation as a guideline.","primaryOutcome":{"measure":"Immunogenicity - Geometric Mean Titer Fold Increase From Baseline","timeFrame":"3 weeks after vaccination (Day 22 ± 2 days)","effectByArm":[{"arm":"Subjects ≥18 to ≤60 Years - AdImmune HA Antigen","deltaMin":3.5,"sd":null},{"arm":"Subjects ≥18 to ≤60 Years - CSL HA Antigen","deltaMin":4,"sd":null},{"arm":"Subjects >60 Years - AdImmune HA Antigen","deltaMin":4.5,"sd":null},{"arm":"Subjects >60 Years - CSL HA Antigen","deltaMin":3.4,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":true,"inclusionCount":3,"exclusionCount":15},"locations":{"siteCount":2,"countries":["Switzerland"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":109},"commonTop":["Pain (at the injection site)","Induration (at the injection site)","Erythema (at the injection site)","Malaise","Chills"]}}